½ÃÀ庸°í¼­
»óǰÄÚµå
1775453

¼¼°èÀÇ UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå ¿¹Ãø(2025-2030³â)

UV Infection Control Devices Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀåÀº CAGR 6.47%·Î 2025³â 6¾ï 291¸¸ ´Þ·¯¿¡¼­ 2030³â 8¾ï 2,490¸¸ 4,000 ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå Á¶»ç´Â ¼¼°èÀÇ UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå¿¡ ´ëÇÑ °£°áÇÑ ºÐ¼®À» Á¦°øÇÏ¿© ÀÇ·á, ½ÄÀ½·á ¹× °ü·Ã ºÐ¾ßÀÇ ¾÷°è Àü¹®°¡µé¿¡°Ô Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. Àü¹®°¡µéÀ» À§ÇØ ÀÛ¼ºµÈ ÀÌ ¿ä¾àº»Àº 2023³â ÀÌÈÄÀÇ ¹ßÀü¿¡ ÃÊÁ¡À» ¸ÂÃß°í, ±× ÀÌÀüÀÇ µ¥ÀÌÅÍ´Â Á¦¿ÜÇÏ¿© 2025³â ÇöÀç ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä µ¿Çâ, ¼ºÀå µ¿·Â ¹× Áö¿ªÀû ¿ªÇÐ °ü°è¸¦ °­Á¶ÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº UV °ü·Ã Àç·áÀÇ ¼º´É ÀúÇÏ¿Í °°Àº ¹®Á¦¿¡µµ ºÒ±¸Çϰí, º´¿ø °¨¿°(HAI)¿¡ ´ëÃ³ÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí, UV ±â¼úÀÌ ¹ßÀüÇϸç, ½Äǰ ¹× À½·á ºÎ¹®°ú ÀÇ·á °ü±¤ÀÇ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °­·ÂÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù.

UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå ¿¬±¸´Â ÀÇ·á ȯ°æ¿¡¼­ ȯÀÚ¿Í Á÷¿ø¿¡°Ô ½É°¢ÇÑ À§ÇèÀ» ÃÊ·¡ÇÏ´Â HAI¿¡ ´ëóÇÏ´Â µ¥ UV ÀåÄ¡ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶ÇÕ´Ï´Ù. »ì±Õ UV ±¤¼±À» ÀÌ¿ëÇÏ´Â UV °¨¿° Á¦¾î ÀåÄ¡´Â ¼öµ¿ û¼Ò »çÀÌÀÇ ¼Òµ¶À» °­È­Çϱâ À§ÇØ ÀÇ·á ÇÁ·ÎÅäÄÝ¿¡ Á¡Á¡ ´õ ÅëÇյǰí ÀÖ½À´Ï´Ù. 2023³âÀÇ ÁÖ¸ñÇÒ ¸¸ÇÑ ¹ßÀüÀ¸·Î´Â Spectralink¿Í Advanced Ultra-Violet Systems (AUVS)°¡ Spectralink Versity ½º¸¶Æ®Æù°ú ȣȯµÇ´Â AUVS UV BoxÀÇ »ç¿ëÀ» ½ÂÀÎÇÑ °ÍÀÔ´Ï´Ù. ÀÌ UV »ì±Õ ÄÉÀ̽º´Â ¿ÍÀÌÇÁ ¾øÀÌ ±â±â¸¦ ¼Òµ¶Çϸç, UV ³ëÃâ¿¡ ´ëÇÑ ³»±¸¼ºÀ» È®º¸ÇØ HAI À§ÇèÀ» ÁÙÀÌ´Â µ¿½Ã¿¡ Çõ½ÅÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °¨¿° °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ »ê¾÷ÀÇ commitment¸¦ º¸¿©ÁÝ´Ï´Ù.

UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå Á¶»ç¿¡¼­ °­Á¶µÈ ¹Ù¿Í °°ÀÌ, ½ÄÀ½·á ºÎ¹®µµ ¶Ç ´Ù¸¥ ÁÖ¿ä ¼ºÀå µ¿·ÂÀÔ´Ï´Ù. UV ÀåÄ¡´Â ¾×ü ¼Òµ¶Á¦¿¡¼­ ¾î·Á¿î ¹®Á¦ÀÎ Àç·áÀÇ Ç³¹Ì¸¦ À¯ÁöÇϸ鼭 ±³Â÷ ¿À¿°À» ¹æÁöÇÕ´Ï´Ù. 2023³â¿¡ ¿þ½ºÆ¾ ÈÞ½ºÅÏ ¸ÞµðÄà ¼¾ÅÍ´Â Xenex Disinfection ServicesÀÇ LightStrike(TM) Germ-Zapping Robots(TM)¸¦ äÅÃÇÏ¿© ÆÞ½º Á¦³í UV ±¤¼±À» »ç¿ëÇÏ¿© °´½Ç°ú °ø¿ë °ø°£À» ¼Òµ¶Çß½À´Ï´Ù. ÀÌ ±â¼úÀº ¹ÙÀÌ·¯½º, ¹ÚÅ׸®¾Æ ¹× °õÆÎÀ̸¦ È¿°úÀûÀ¸·Î Á¦°ÅÇÏ¿© ±³Åë·®ÀÌ ¸¹Àº ȯ°æ¿¡¼­ ¾ö°ÝÇÑ À§»ý ±âÁØÀ» Áö¿øÇÏ°í ºñÀÇ·á ºÐ¾ß¿¡¼­ÀÇ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÕ´Ï´Ù.

Áö¿ªÀûÀ¸·Î ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC) ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA) Áö¿ªÀº ÀÇ·á °ü±¤ÀÇ È®´ë·Î ÀÎÇØ »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. Àεµ ¹× ¾Æ¶ø¿¡¹Ì¸®Æ®¿Í °°Àº ±¹°¡µéÀº ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­Çϰí, ÀεµÀÇ 3ȸ ÀÔ±¹ ÀüÀÚ ÀÇ·á ºñÀÚ µî ¼±ÅÃÀû ¹× º¹ÀâÇÑ ½Ã¼úÀ» ¿øÇÏ´Â ÀÇ·á °ü±¤°´À» À¯Ä¡Çϱâ À§ÇÑ Á¤Ã¥À» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå ¿¬±¸¿¡ µû¸£¸é ÀÌ·¯ÇÑ À¯ÀÔÀ¸·Î ÀÎÇØ ¾ö°ÝÇÑ °¨¿° ¿¹¹æÀÌ Áß¿äÇÑ ÀÇ·á ½Ã¼³, ¼÷¹Ú ½Ã¼³ ¹× ½Äǰ ¼­ºñ½º¿¡¼­ UV ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ¹ßÀü¿¡µµ ºÒ±¸Çϰí Àڿܼ±ÀÌ Àç·á¸¦ ¼Õ»ó½Ãų °¡´É¼ºÀÌ ÀÖ¾î ÀåÄ¡ÀÇ ¼ö¸íÀ» º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ Å×½ºÆ®°¡ ÇÊ¿äÇÏ´Ù´Â µî °úÁ¦°¡ ³²¾Æ ÀÖ½À´Ï´Ù. UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå ¿¬±¸´Â À§»ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö´Â °Í°ú ÇÔ²² IoT ÅëÇÕ UV ½Ã½ºÅÛ ¹× ÈÞ´ë¿ë ÀåÄ¡¿Í °°Àº ±â¼ú Çõ½Å¿¡ ÈûÀÔ¾î ½ÃÀåÀÌ °è¼Ó È®´ëµÉ °ÍÀ¸·Î Àü¸ÁÇÕ´Ï´Ù. ºÏ¹Ì´Â ¼±Áø ÀÇ·á ÀÎÇÁ¶ó·Î ÀÎÇØ ÁÖ¿ä ½ÃÀåÀ¸·Î ³²¾Æ ÀÖÀ¸¸ç, APACÀÇ ±Þ¼ÓÇÑ ¼ºÀåÀº Àα¸ ¹Ðµµ¿Í ÀÇ·á °ü±¤¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

°á·ÐÀûÀ¸·Î, UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå ¿¬±¸´Â ÀÇ·á ¹× ½Äǰ ¾ÈÀü ¿ä±¸¿¡ ÀÇÇØ ÃßÁøµÇ´Â ½ÃÀå¿¡ ´ëÇÑ Àü·«Àû ÅëÂû·ÂÀ» Á¦°øÇÏ´Â ¾÷°è Àü¹®°¡¿¡°Ô ÇʼöÀûÀÎ ¸®¼Ò½ºÀÔ´Ï´Ù. Spectralink, AUVS ¹× Xenex¿Í °°Àº ±â¾÷ÀÇ Çõ½ÅÀº Àç·áÀÇ ³»±¸¼º ¹®Á¦¿¡µµ ºÒ±¸ÇÏ°í ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ °¨¿° °ü¸®¸¦ °­È­ÇÒ ¼ö ÀÖ´Â ½ÃÀåÀÇ ÀáÀç·ÂÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀÌÁ¡

  • ÅëÂû·Â ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷ ºÐ¾ß ¹× ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃç ÁÖ¿ä Áö¿ª°ú ½ÅÈï Áö¿ªÀ» Æ÷°ýÇÏ´Â ÀÚ¼¼ÇÑ ½ÃÀå ÅëÂû·ÂÀ» È®º¸ÇϽʽÿÀ.
  • °æÀï ȯ°æ : ¼¼°èÀÇ ÁÖ¿ä ¾÷üµéÀÌ »ç¿ëÇÏ´Â Àü·«Àû ±â¹ýÀ» ÀÌÇØÇÏ¿© ¿Ã¹Ù¸¥ Àü·«À¸·Î °¡´ÉÇÑ ½ÃÀå ħÅõ¸¦ ÆÄ¾ÇÇϽʽÿÀ.
  • ½ÃÀå ÃËÁø¿äÀÎ ¹× ¹Ì·¡ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú Áß¿äÇÑ ½ÃÀå µ¿ÇâÀ» ޱ¸Çϰí, ÀÌ·¯ÇÑ ¿äÀÎÀÌ ¹Ì·¡ÀÇ ½ÃÀå ¹ßÀü¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¥Áö ÆÄ¾ÇÇÕ´Ï´Ù.
  • ½ÇÇà °¡´ÉÇÑ ±ÇÀå »çÇ× : ÅëÂû·ÂÀ» Ȱ¿ëÇÏ¿© Àü·«Àû °áÁ¤À» ³»¸®°í, ¿ªµ¿ÀûÀΠȯ°æ¿¡¼­ »õ·Î¿î ºñÁî´Ï½º È帧°ú ¼öÀÍÀ» âÃâÇϼ¼¿ä.
  • ±¤¹üÀ§ÇÑ °í°´Ãþ¿¡ ÀûÇÕ : ½Å»ý ±â¾÷, ¿¬±¸ ±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷ ¹× ´ë±â¾÷¿¡ À¯¿ëÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¿ªÀû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀï Á¤º¸

Á¶»ç ¹üÀ§

  • ½ÇÀû Å×ÀÌÅÍ(2022-2024³â) ¹× ¿¹Ãø µ¥ÀÌÅÍ(2025-2030³â)
  • ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ Ʋ, µ¿Ç⠺м®
  • °æÀï Æ÷Áö¼Å´×, Àü·«, ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¼öÀÍÀÇ ¼ºÀå°ú ¿¹Ãø °¢±¹À» Æ÷ÇÔÇÑ ºÎ¹®¿Í Áö¿ªÀÇ ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫 »óȲ, ÁÖ¿ä ¹ßÀü µî)

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • Á¤Ã¥ ¹× ±ÔÁ¤
  • Àü·«Àû Á¦¾È

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå : À¯Çüº°

  • ¼Ò°³
  • ¸ð¹ÙÀÏ
  • °ÅÄ¡Çü
  • ±âŸ

Á¦6Àå UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • º´¿ø ¹× Áø·á¼Ò
  • Á¦¾à ¹× »ý¸í°úÇÐ ±â¾÷

Á¦7Àå UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå : ±¤¿øº°

  • ¼Ò°³
  • Àڿܼ± C(UVC)
  • Àڿܼ± A(UVA)

Á¦8Àå UV °¨¿° Á¦¾î ÀåÄ¡ ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ½ºÆäÀÎ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • ±âŸ

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ, Äݶ󺸷¹À̼Ç
  • °æÀï ´ë½Ãº¸µå

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • American Ultraviolet, Inc.
  • Atlantic Ultraviolet Corporation
  • AquiSense Technologies
  • Blue Ocean Robotics
  • Crystal IS
  • Halma PLC
  • Kuraray Co., Ltd.
  • R-Zero Systems, Inc.
  • Seal Shield, LLC
  • STERIS plc.

Á¦11Àå ºÎ·Ï

  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ ¹× ¿¹Ãø¿¬µµÀÇ Å¸ÀÓ¶óÀÎ
  • ÀÌÇØ °ü°èÀÚ¿¡°Ô À־ÀÇ ÁÖ¿ä ÀÌÁ¡
  • Á¶»ç ¹æ¹ý
  • ¾à¾î
HBR 25.08.01

The UV Infection Control Devices Market is expected to grow from USD 602.910 million in 2025 to USD 824.904 million in 2030, at a CAGR of 6.47%.

The UV Infection Control Devices Market Study provides a concise analysis of the global UV infection control devices market, delivering critical insights for industry experts in healthcare, food and beverage, and related sectors. This summary, tailored for professionals, highlights key trends, growth drivers, and geographical dynamics shaping the market as of 2025, focusing on developments from 2023 onward and excluding earlier data. The market is experiencing robust growth driven by the rising need to combat hospital-acquired infections (HAIs), advancements in UV technology, and increasing demand from the food and beverage sector and medical tourism, despite challenges like UV-related material degradation.

The UV Infection Control Devices Market Study emphasizes the critical role of UV devices in addressing HAIs, which pose significant risks to patients and staff in healthcare settings. UV infection control devices, utilizing germicidal UV light, are increasingly integrated into healthcare protocols to enhance disinfection between manual cleanings. A notable 2023 development involves Spectralink and Advanced Ultra-Violet Systems (AUVS) approving the AUVS UV Box for use with Spectralink Versity smartphones. This UV germicidal enclosure disinfects devices without wipes, reducing HAI risks while ensuring durability against UV exposure, showcasing the industry's commitment to innovative, reliable infection control solutions.

The food and beverage sector is another key growth driver, as highlighted in the UV Infection Control Devices Market Study. UV devices prevent cross-contamination while preserving ingredient flavors, a challenge with liquid disinfectants. In 2023, The Westin Houston Medical Centre adopted Xenex Disinfection Services' LightStrike(TM) Germ-Zapping Robots(TM), using pulsed xenon UV light to disinfect guest rooms and common areas. This technology effectively eliminates viruses, bacteria, and fungi, supporting stringent hygiene standards in high-traffic environments and driving market growth in non-healthcare applications.

Geographically, the Asia-Pacific (APAC) and Middle East and Africa (MEA) regions are poised for significant growth due to expanding medical tourism. Countries like India and the United Arab Emirates are enhancing healthcare infrastructure and implementing policies, such as India's triple-entry e-Medical visas, to attract medical tourists seeking elective and complex procedures. The UV Infection Control Devices Market Study notes that this influx increases demand for UV devices in healthcare facilities, accommodations, and food services, where strict infection prevention is critical to cater to international patients.

Despite these advancements, challenges persist, including UV light's potential to damage materials, necessitating rigorous testing to ensure device longevity. The UV Infection Control Devices Market Study projects continued market expansion, driven by technological innovations like IoT-integrated UV systems and portable devices, alongside growing hygiene awareness. North America remains a key market due to advanced healthcare infrastructure, while APAC's rapid growth is fueled by population density and medical tourism.

In conclusion, the UV Infection Control Devices Market Study is an essential resource for industry experts, offering strategic insights into a market propelled by healthcare and food safety needs. Innovations from companies like Spectralink, AUVS, and Xenex underscore the market's potential to enhance infection control across diverse sectors, despite material durability challenges.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

  • Mobile
  • Stationary
  • Others

By End-User

  • Hospitals & Clinics
  • Pharmaceutical & Life Science Companies

By Light Source

  • Ultraviolet-C (UVC)
  • Ultraviolet-A (UVA)

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Indonesia
  • Thailand
  • South Korea
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. UV INFECTION CONTROL DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Mobile
  • 5.3. Stationary
  • 5.4. Others

6. UV INFECTION CONTROL DEVICES MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals & Clinics
  • 6.3. Pharmaceutical & Life Science Companies

7. UV INFECTION CONTROL DEVICES MARKET BY LIGHT SOURCE

  • 7.1. Introduction
  • 7.2. Ultraviolet-C (UVC)
  • 7.3. Ultraviolet-A (UVA)

8. UV INFECTION CONTROL DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Australia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. American Ultraviolet, Inc.
  • 10.2. Atlantic Ultraviolet Corporation
  • 10.3. AquiSense Technologies
  • 10.4. Blue Ocean Robotics
  • 10.5. Crystal IS
  • 10.6. Halma PLC
  • 10.7. Kuraray Co., Ltd.
  • 10.8. R-Zero Systems, Inc.
  • 10.9. Seal Shield, LLC
  • 10.10. STERIS plc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦